Anales RANF

Hanan Awad Alkozi @Real Academia Nacional de Farmacia. Spain 58 45. Sanchez-Bretano A, Baba K, Janjua U, Piano I, Gargini C, Tosini G. Melatonin partially protects 661W cells from H2O2-induced death by inhibiting Fas/FasL-caspase-3. Mol Vis. 2017;23:844-52. 46. Alkozi H, Sanchez-Naves J, de Lara MJ, Carracedo G, Fonseca B, Martinez-Aguila A, et al. Elevated intraocular pressure increases melatonin levels in the aqueous humour. Acta Ophthalmol. 2016. 47. Ma XP, Shen MY, Shen GL, Qi QR, Sun XH. Melatonin concentrations in serum of primary glaucoma patients. Int J Ophthalmol. 2018;11(8):1337-41. 48. Alkozi HA, Perez de Lara MJ, Sanchez-Naves J, Pintor J. TRPV4 Stimulation Induced Melatonin Secretion by Increasing Arylalkymine N- acetyltransferase (AANAT) Protein Level. Int J Mol Sci. 2017;18(4). 49. Alkozi HA, Pintor J. TRPV4 activation triggers the release of melatonin from human non-pigmented ciliary epithelial cells. Exp Eye Res. 2015;136:34-7. 50. Klein DC, Coon SL, Roseboom PH, Weller JL, Bernard M, Gastel JA, et al. The melatonin rhythm- generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res. 1997;52:307-57; discussion 57-8. 51. Gastel JA, Roseboom PH, Rinaldi PA, Weller JL, Klein DC. Melatonin production: proteasomal proteolysis in serotonin N-acetyltransferase regulation. Science. 1998;279(5355):1358-60. 52. Alkozi HA, Perez de Lara MJ, Pintor J. Melatonin synthesis in the human ciliary body triggered by TRPV4 activation: Involvement of AANAT phosphorylation. Exp Eye Res. 2017;162:1-8. 53. Aydin E, Sahin S. Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(5):721-4. 54. Tutuncu NB, Batur MK, Yildirir A, Tutuncu T, Deger A, Koray Z, et al. Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. J Pineal Res. 2005;39(1):43-9. 55. Chen W, Cao H, Lu QY, Wang N, Zhao SZ, Xu X, et al. Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes. Int J Clin Exp Pathol. 2014;7(7):4317-22. 56. Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol. 2009;38(4):963-70. 57. Aubrecht TG, Jenkins R, Nelson RJ. Dim light at night increases body mass of female mice. Chronobiol Int. 2015;32(4):557-60. 58. Stevens RG. Artificial lighting in the industrialized world: circadian disruption and breast cancer. Cancer Causes Control. 2006;17(4):501-7. 59. Keeler CE. The Geotropic Reaction of Rodless Mice in Light and in Darkness. J Gen Physiol. 1928;11(4):361-8. 60. Foster RG. Shedding light on the biological clock. Neuron. 1998;20(5):829-32. 61. Provencio I, Jiang G, De Grip WJ, Hayes WP, Rollag MD. Melanopsin: An opsin in melanophores, brain, and eye. Proc Natl Acad Sci U S A. 1998;95(1):340-5. 62. Contin MA, Verra DM, Guido ME. An invertebrate- like phototransduction cascade mediates light detection in the chicken retinal ganglion cells. FASEB J. 2006;20(14):2648-50. 63. Qiu X, Kumbalasiri T, Carlson SM, Wong KY, Krishna V, Provencio I, et al. Induction of photosensitivity by heterologous expression of melanopsin. Nature. 2005;433(7027):745-9. 64. Koyanagi M, Kubokawa K, Tsukamoto H, Shichida Y, Terakita A. Cephalochordate melanopsin: evolutionary linkage between invertebrate visual cells and vertebrate photosensitive retinal ganglion cells. Curr Biol. 2005;15(11):1065-9. 65. Koyanagi M, Terakita A. Gq-coupled rhodopsin subfamily composed of invertebrate visual pigment and melanopsin. Photochem Photobiol. 2008;84(4):1024-30. 66. Valdez DJ, Nieto PS, Garbarino-Pico E, Avalle LB, Diaz-Fajreldines H, Schurrer C, et al. A nonmammalian vertebrate model of blindness reveals functional photoreceptors in the inner retina. FASEB J. 2009;23(4):1186-95. 67. Quera Salva MA, Hartley S, Leger D, Dauvilliers YA. Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. Front Neurol. 2017;8:686. 68. Lockley SW, Dijk DJ, Kosti O, Skene DJ, Arendt J. Alertness, mood and performance rhythm disturbances associated with circadian sleep disorders in the blind. J Sleep Res. 2008;17(2):207-16. 69. Lockley SW, Arendt J, Skene DJ. Visual impairment and circadian rhythm disorders. Dialogues Clin Neurosci. 2007;9(3):301-14. 70. Alkozi HA, Wang X, Perez de Lara MJ, Pintor J. Presence of melanopsin in human crystalline lens epithelial cells and its role in melatonin synthesis. Exp Eye Res. 2016. 71. Delwig A, Chaney SY, Bertke AS, Verweij J, Quirce S, Larsen DD, et al. Melanopsin expression in the cornea. Vis Neurosci. 2018;35:E004. 72. Matynia A, Nguyen E, Sun X, Blixt FW, Parikh S, Kessler J, et al. Peripheral Sensory Neurons Expressing Melanopsin Respond to Light. Front Neural Circuits. 2016;10:60. 73. Aldahan AS, Shah VV, Mlacker S, Nouri K. Sun Exposure in History. JAMA Dermatol. 2016;152(8):896.